Page 47 - GPD-2-4

Gene & Protein in Disease Cyanine and cancer therapy

https://doi.org/10.1186/1756-9966-30-87 https://doi.org/10.1006/scbi.1998.0098
76. Kale J, Osterlund EJ, Andrews DW, 2018, Bcl-2 family 89. McMahon SB, 2014, Myc and the control of apoptosis. Cold
proteins: Changing partners in the dance towards death. Cell Spring Harb Perspect Med, 4: a014407.
Death Differ,25: 65–80. https://doi.org/10.1101/cshperspect.a014407
https://doi.org/10.1038/cdd.2017.186
90. Smith GC, d’Adda di Fagagna F, Lakin ND, 1999, Cleavage
77. Yang R, Dong H, Jia S, 2022, Resveratrol as a modulatory and inactivation of Atm during apoptosis. Mol Cell Biol,
of apoptosis and autophagy in cancer therapy. Clin Transl 19: 6076–6084.
Oncol, 24: 1219–1230.
https://doi.org/10.1128/mcb.19.9.6076
https://doi.org/10.1007/s12094-021-02770-y
91. Bleicken S, Jeschke G, Stegmueller C, et al., 2014, Structural
78. Siddiqui WA, Ahad A, Ahsan H, 2015, The mystery of model of active bax at the membrane. Mol Cell, 56: 496–505.
Bcl2 family: Bcl-2 proteins and apoptosis: An update. Arch https://doi.org/10.1016/j.molcel.2014.09.022
Toxicol, 89: 289–317.
92. Borner C, Andrews DW, 2014, The apoptotic pore on
https://doi.org/10.1007/s00204-014-1448-7 mitochondria: Are we breaking through or still stuck? Cell
79. Harada H, Grant S, 2003, Apoptosis regulators. Rev Clin Exp Death Differ, 21: 187–191.
Hematol, 7: 117–138.
https://doi.org/10.1038/cdd.2013.169
80. Wang K, Yin XM, Chao DT, et al., 1996, Bid: A novel Bh3 93. Jeong SH, Lee HW, Han JH, et al., 2008, Low expression of
domain-only death agonist. Genes Dev, 10: 2859–2869.
bax predicts poor prognosis in resected non-small cell lung
https://doi.org/10.1101/gad.10.22.2859 cancer patients with non-squamous histology. Jpn J Clin
Oncol, 38: 661–669.
81. O’Connor L, Strasser A, O’Reilly LA, et al., 1998, Bim:
A novel member of the Bcl-2 family that promotes apoptosis. https://doi.org/10.1093/jjco/hyn089
EMBO J, 17: 384–395. 94. Schuyer M, van der Burg ME, Henzen-Logmans SC,
https://doi.org/10.1093/emboj/17.2.384 et al., 2001, Reduced expression of bax is associated with
poor prognosis in patients with epithelial ovarian cancer:
82. Nakano K, Vousden KH, 2001, PUMA, a novel proapoptotic
gene, is induced by P53. Mol Cell, 7: 683–694. A multifactorial analysis of Tp53, P21, Bax and Bcl-2. Br J
Cancer, 85: 1359–1367.
https://doi.org/10.1016/s1097-2765(01)00214-3
https://doi.org/10.1054/bjoc.2001.2101
83. Cory S, Huang DC, Adams JM, 2003, The Bcl-2 family: Roles 95. Indran IR, Tufo G, Pervaiz S, et al., 2011, Recent advances in
in cell survival and oncogenesis. Oncogene, 22: 8590–8607.
apoptosis, mitochondria and drug resistance in cancer cells.
https://doi.org/10.1038/sj.onc.1207102 Biochim Biophys Acta, 1807: 735–745.
84. Gross A, McDonnell JM, Korsmeyer SJ, 1999, Bcl-2 family https://doi.org/10.1054/bjoc.2001.2101
members and the mitochondria in apoptosis. Genes Dev,
13: 1899–1911. 96. Miquel C, Borrini F, Grandjouan S, et al., 2005, Role of
bax mutations in apoptosis in colorectal cancers with
https://doi.org/10.1101/gad.13.15.1899 microsatellite instability. Am J Clin Pathol, 123: 562–570.
85. Shakeri R, Kheirollahi A, Davoodi J, 2017, Apaf-1: Regulation https://doi.org/10.1309/JQ2X-3RV3-L8F9-TGYW
and function in cell death. Biochimie, 135: 111–125.
97. Pepper C, Hoy T, Bentley DP, 1997, Bcl-2/Bax ratios in chronic
https://doi.org/10.1016/j.biochi.2017.02.001 lymphocytic leukaemia and their correlation with in vitro
apoptosis and clinical resistance. Br J Cancer, 76: 935–938.
86. Bruckheimer EM, Cho SH, Sarkiss M, et al., 1998, The Bcl-2
gene family and apoptosis. Adv Biochem Eng Biotechnol, https://doi.org/10.1038/bjc.1997.487
62: 75–105.
98. Soengas MS, Capodieci P, Polsky D, et al., 2001, Lowe
https://doi.org/10.1007/BFb0102306 inactivation of the apoptosis effector Apaf-1 in malignant
melanoma. Nature, 409: 207–211.
87. Gloire G, Charlier E, Piette J, 2008, Regulation of Cd95/
Apo-1/Fas-induced apoptosis by protein phosphatases. https://doi.org/10.1038/35051606
Biochem Pharmacol, 76: 1451–1458.
99. Baldi A, Santini D, Russo P, et al., 2004, Analysis of Apaf-1
https://doi.org/10.1016/j.bcp.2008.06.023 expression in human cutaneous melanoma progression. Exp
Dermatol, 13: 93–97.
88. Gottlieb TM, Oren M, 1998, P53 and apoptosis. Semin
Cancer Biol, 8: 359–368. https://doi.org/10.1111/j.0906-6705.2004.00136.x

Volume 2 Issue 4 (2023) 16 https://doi.org/10.36922/gpd.2486